IL10 and colitis: Therefore, since IL-10 appears to modulate inflammasome activation, an in vivo pharmacological modulation of IL-10 in animal models of hapten-induced colitis could help to unravel the mechanisms underlying the negative regulation of inflammasome by IL-10.